TD Asset Management Inc. lowered its position in shares of Humana Inc. (NYSE:HUM) by 15.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 225,348 shares of the insurance provider’s stock after selling 42,324 shares during the period. TD Asset Management Inc. owned 0.15% of Humana worth $39,862,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in HUM. Point72 Asia Hong Kong Ltd purchased a new stake in Humana during the second quarter worth approximately $126,000. Daiwa SB Investments Ltd. boosted its stake in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock worth $129,000 after buying an additional 10 shares during the last quarter. Markston International LLC purchased a new stake in Humana during the third quarter worth approximately $159,000. Bessemer Group Inc. boosted its stake in Humana by 14.0% in the second quarter. Bessemer Group Inc. now owns 1,140 shares of the insurance provider’s stock worth $205,000 after buying an additional 140 shares during the last quarter. Finally, Fulton Bank N.A. purchased a new stake in Humana during the third quarter worth approximately $229,000. 91.71% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Shares of Humana Inc. (NYSE:HUM) traded up 0.11% during mid-day trading on Monday, reaching $208.10. 981,647 shares of the company’s stock were exchanged. Humana Inc. has a 1-year low of $150.00 and a 1-year high of $210.30. The company’s 50 day moving average is $182.00 and its 200 day moving average is $177.35. The stock has a market capitalization of $31.03 billion, a PE ratio of 28.14 and a beta of 0.80.

Humana (NYSE:HUM) last issued its quarterly earnings results on Friday, November 4th. The insurance provider reported $3.18 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.09 by $0.09. Humana had a net margin of 2.00% and a return on equity of 12.32%. The business had revenue of $13.69 billion for the quarter, compared to analyst estimates of $13.41 billion. During the same quarter in the prior year, the business posted $2.16 EPS. Humana’s revenue for the quarter was up 2.5% compared to the same quarter last year. Equities research analysts anticipate that Humana Inc. will post $9.51 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Thursday, January 12th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.56%. The ex-dividend date is Tuesday, January 10th. Humana’s dividend payout ratio (DPR) is currently 15.96%.

COPYRIGHT VIOLATION WARNING: This article was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this article can be read at https://www.thecerbatgem.com/2016/11/28/td-asset-management-inc-has-39862000-position-in-humana-inc-hum.html.

A number of equities research analysts have recently commented on the stock. Credit Suisse Group AG reiterated a “hold” rating and set a $188.00 price target on shares of Humana in a report on Tuesday, September 13th. Barclays PLC cut their price target on shares of Humana from $193.00 to $191.00 and set an “equal weight” rating on the stock in a report on Thursday, August 4th. Jefferies Group reiterated a “buy” rating and set a $206.00 price target on shares of Humana in a report on Monday, November 7th. Cantor Fitzgerald reiterated a “buy” rating on shares of Humana in a report on Monday, August 8th. Finally, JPMorgan Chase & Co. upgraded shares of Humana from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $163.00 to $202.00 in a report on Thursday, November 10th. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $205.00.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.